Skip to main content
Premium Trial:

Request an Annual Quote

Syrrx Hires Norman Halleen as Chief Financial Officer

NEW YORK, April 26 – Syrrx has appointed Norman Halleen to the position of vice president of finance and chief financial officer, a new position, the company said Thursday.

Halleen comes to the company from Aradigm, a maker of drug delivery systems, where he served as CFO and vice president of finance. 

Syrrx needed a CFO, said Nathaniel David, the company’s director of business development, because the company should be in a position to “examine other sources of financing,” including preparing for an initial public offering.

While David said the company has no immediate plans for an IPO, he added that hiring a CFO was important for a company of Syrrx’s size—meaning the number of employees and amount of money the company has to spend.

“It makes sense to prepare ourselves for more complex [financial] transactions,” David said.

Halleen will be responsible for finance, facilities, and investor relations for the company.
The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.